Skip to main content
. Author manuscript; available in PMC: 2021 Dec 8.
Published in final edited form as: J Am Coll Cardiol. 2020 Dec 8;76(23):2755–2763. doi: 10.1016/j.jacc.2020.10.003

Table 5:

Comparison of Correlation coefficients (r) and Slopes (β coefficient) Between Models Based on PVRrest vs Models Based on mPAP/CO slope

End-organ function PVRrest r (p) mPAP/CO slope r (p) Meng test p PVRrest β (95%CI) mPAP/CO slope β (95%CI) p
Endothelial function
EndoPAT-derived RHI −0.31 (0.04) −0.63 (<0.001) 0.02 −0.06 (−0.12 – −0.01) −0.11 (−0.18 – −0.0) <0.001
End-organ function
MRE liver stiffness 0.29 (0.04) 0.47 (0.008) 0.07 0.08 (0.02 – 1.98) 0.21 (2.84 – 5.57) <0.001
GFR −0.24 (0.07) −0.52 (<0.001) 0.03 −0.03 (−0.07 – 0.01) −0.09 (−0.13 – −0.04) 0.008
NT-proBNP 0.17 (0.2) 0.56 (<0.001) 0.02 0.05 (−0.13 – 0.19) 0.26 (0.14 – 0.39) <0.001
Est plasma volume 0.08 (0.5) 0.24 (0.1) 0.4 0.01 (−0.16 – 0.14) 0.06 (−0.09 – 0.21) 0.2
Peak VO2 −0.26 (0.09) −0.63 (<0.001) 0.02 −0.06 (−0.11 – 0.02) −0.19 (−0.30 – −0.04) 0.01
MLHFQ 0.22 (0.1) 0.28 (0.08) 0.4 0.01 (−0.18 – 0.20) 0.07 (−0.03 – 0.15) 0.5

PVR: pulmonary vascular resistance; mPAP/CO slope: slope of mean pulmonary artery pressure versus cardiac output; RHI: reactive hyperemia index; MRE: magnetic resonance elastography; GFR: glomerular filtration rate; NT proBNP: N-terminal pro hormone brain natriuretic peptide; VO2: oxygen consumption; MLHFQ: Minnesota living with heart failure questionnaire; CI: confidence interval